Molecular Assemblies, Inc.’s Post

Accelerate the scaling of bioprocesses and commercial production. Let's make a real impact - together!

Research and Development's Role The challenging, yet enjoyable, role of R&D involves embodying the perspective of the end user during formulation. It's essential for R&D professionals to anticipate the user's needs for ease and comfort when applying the product. Additionally, they must discern market demands for the new product and strategize formulations to deliver superior qualities that meet these needs, which can present its own set of challenges. Furthermore, R&D professionals must consider the feasibility and efficiency of the production process. It's imperative to optimize raw material costs to maximize the company's margins and ensure the product's competitiveness in the market. Lastly, R&D plays a crucial role in supporting marketing efforts during product launches. These tasks are undeniably exciting, especially when the market responds positively and is satisfied with the product. The culmination of R&D's efforts is truly rewarding when it translates into consumer acceptance and success in the marketplace. Please enjoy this videoclip of our new product line: Primafix Wall Finish Wait for the next video of our customer's testimony Happy Monday!

🌟 We're on the Hunt for a #MarketingTeamLead! 🌟 At PROTEINA, we're not just making strides; we're changing the game in the realm of precision medicine. With our groundbreaking Single-molecule Protein-protein Interaction Detection (SPID) platform, we're leading the charge in discovering and developing first-in-class precision medicines. And now, we're looking for a Marketing Team Lead who's ready to help steer our mission to new heights. 📌 Here's what we're looking for: ✅ Strategic Mastery: Someone who can craft and execute long-term marketing plans and strategies with finesse. ✅ Market Savvy: A pro at conducting thorough market research and analysis in the healthcare sector, including pharmaceuticals, biotech, and medical devices. ✅ Sales Strategy Expertise: An innovator ready to develop and implement sales strategies and market activation plans for our leading products. ✅ Event Planning Excellence: A planner and a doer who can orchestrate our participation in both domestic and international academic conferences and exhibitions. If you found yourself nodding along, thinking, "This is exactly where I need to be," we're looking for YOU. Let's not be strangers. Reach out, and let's explore how we can revolutionize the world of precision medicine together. 🔗 Curious? Excited? For more details on this role and to apply, click the link below. Let's make something incredible happen. 👉 https://lnkd.in/g8XmHR_A #Hiring #MarketingTeamLead #PrecisionMedicine #Healthcare #Innovation #PROTEINA #PPI

To All My Dear Connections: Merry Christmas! The attached picture is a Christmas Tree made of two beautiful written Chinese characters: "钱来” - it means "money comes". And on the top of the tree (and below the tree), the shinny yellow (and the solid brown) Chinese characters mean "Money comes from all directions" - well, as an employee myself, I would say this Christmas tree is filled with best wishes:) I wish that I can match the right opportunity for any one of you who is actively looking for new opportunities out there, and that I can bring luck and wealth to you by introducing that right opportunity^^ You are welcome to check out the main opportunities below that I am handling: 1. Chief Marketing Officer - A Biotech Research Company - US (>20 peeple's team management experience + service product + commercial sense) 2. Chief Business Officer - A Cell Therapy Pharma - US (experiences in out-licensing & CGT area) 3. Head of Regulatory Affairs - A Cell Therapy Pharma - US (CGT submission experiences is a MUST) 4. Chief Finance Officer - A Pharmaceutical Company - Remote (if you had demonstrated experiences in both HK/US IPO, this will be a good fit for you!) I can't wait to discuss more with you - let's have a virtual "coffee chat"!

As Christopher Lochhead🏴☠️ taught me, if you are by definition a substantially equivalent product, you have consciously or unconsciously made a decision to play the “better” game not the “different” game. You will be competing against another brand by comparing yourself to other equivalent options to demonstrate you’re superior. You might claim you’re faster, cheaper, more efficient — which means you think you’re “better” — than another product. However, your target audience is already using a product they’re probably fairly satisfied with or a product that does the job they need. And you’re now trying to convince them your option is incrementally better. Just look at your data! But that’s not enough to get them to switch to a new product. Because what you really are is a “nice to have” product and not a “must have” product. Because you haven’t found something different to solve for them that would deliver exponential — and exclusive — value. Rather than falling into a never-ending comparison competition, your goal should be to clearly and specifically differentiate yourself from the legacy category. This forces a choice not a comparison. When done well, your audience will see why you’re the unrivaled solution. Ideally, this "different discovery" should happen before you get locked into your regulatory path. But if you believe your product is truly different and you're seeing sluggish adoption, please contact me. We help innovative life sciences companies make the competition irrelevant.

As a CEO of a Life Sciences company you know that navigating the complex landscape of commercial approval in the life sciences industry requires strategic foresight, a deep understanding of market needs, and a relentless focus on creating meaningful value for customers. While the fastest regulatory path to approval may seem appealing, it could potentially be a double-edged sword. Why? Because your regulatory pathway significantly impacts your product positioning and sales strategy. For instance, pursuing a 510(k) clearance might seem like a smart move—it lowers costs and allows for earlier sales. But if you're offering a product that's substantially equivalent to what's already out there, you might encounter a lukewarm reception and low adoption rates. Your product could end up being seen as a "nice to have" rather than a "must-have." In the dynamic world of life sciences, playing a longer-term, more strategic game is essential. It's not just about getting your product to market quickly—it's about building market demand and generating significant revenue. So, don't be shortsighted. At Grey Matter Marketing, we understand these challenges. We're here to guide you through the complexities, helping you make strategic decisions that position your product uniquely and drive market demand. Contact us to learn more: https://ow.ly/wQJo50Q4GOS #ChallengetheStatusQuo #CategoryDrivenGrowth #LifeSciencesExperts

If you’re moving towards going to market with your Life Sciences company, congratulations! You’ve likely navigated complex product development and are on your way to satisfying the regulatory and clinical requirements necessary to start selling. But as you begin to transition into more commercial and promotional communication, you need to make sure your marketing won't open up your nascent company to risk. We see early-stage founders struggle with this from time to time at Innosphere Ventures. They successfully deal with all the nuances of the product development process, but then they aren’t aware of all the potential pitfalls of their communication strategy, which opens them up to unnecessary risk. For example, they are eager to get their website up to drive and capture interest. But they state their product name, along with a claim, in the public domain without getting the required FDA approval first. This can invite some very unwelcome scrutiny from regulatory bodies. Or, they’ll share too much proprietary information in a published paper or presentation early on, which can make it hard for them to protect their competitive advantage or their IP as they grow. Life Sciences founders are entering a very complex and highly regulated commercial environment. Taking the time to make sure they really understand how to dot their i’s and cross their t’s within their marketing and communication strategy is critical. That way, they can ensure that all their hard go-to-market work maintains its momentum towards their product launch.

Company posts rarely work in biotech. It’s a combination of 3 things: 1. LinkedIn represses company page posts Personal account posts are preferred. Company reach outside the organization? Less than 20% of what a personal post can. Bad return on investment. 2. Scientists don’t trust company pages You’re not selling to the general population. You’re selling science to some of the most intelligent and skeptical people on the planet. They engage with the opinions and findings of trusted peers and peer-reviewed information. A company page can (almost) never be that trusted source. It’s too biased. 3. The content is boring and self-serving Sorry. It needs to be said. Most posts fall into these categories: - Learn about how WE are awesome! - Come meet US at a conference! - Go view OUR webinar! - GIMME your email! - Visit the website! The underlying message? Give something I haven’t earned so I can take advantage of you. No one is interested in that. Alright. So what should be done instead? Stay tuned. I’ll be covering this in the weeks to come :) #marketing #biotechnology #cellandgenetherapy

For those of you doing a job search, here's an example of my search that returns a fairly good rate of interesting roles. Repost if you find this helpful. The structure is basically (grade) AND (role) AND (industry). Don't forget quotes or opening and closing parentheses. What would you add to my list (or post your own searches below)? ("Vice President" OR "VP" OR "Assistant Vice President" OR "AVP" OR "Senior Director" OR "Director" OR "Associate Director" OR "Chief" OR "Head" OR "Lead") AND ("Commercial Operations" OR "Commercial" OR "Strategy" OR "Strategic Planning" OR "Marketing" OR "Sales" OR "Business Development" OR "Product Management" OR "Market Access" OR "Customer Success" OR "Brand Management" OR "Growth" OR "Corporate Development" OR "Innovation" OR "Digital Transformation") AND ("Life Sciences" OR "Biotechnology" OR "Pharmaceuticals" OR "Biopharmaceuticals" OR "Cell and Gene Therapy" OR "CGT" OR "Genomics" OR "Precision Medicine" OR "Healthcare Technology") I'll leave this as a pinned post for my own reference so I don't have to keep going back to my .txt file. Ali Divan, Ph.D. Anis Fahandej-Sadi

HappiLabs Virtual Lab Managers are experts in the scientific #supplychain. We recently worked with interns from the University of IL-Chicago to analyze 70 strategic #lifescience suppliers, and are releasing a series of blog posts to discuss our findings to provide lab managers and #procurement professionals with insights. See our breakdown of the location of common and uncommon suppliers in this industry. How does supplier location influence your lab's decision making related to purchasing? https://lnkd.in/g6TigHgX